Filed Pursuant to Rule 424(b)(5)
Registration No. 333-249932
PROSPECTUS SUPPLEMENT
(To Prospectus dated November 6, 2020)
$1,250,000,000
Common Stock
We have entered into separate equity distribution agreements each dated as of February 17, 2023, with each of BofA Securities, Inc., BTIG, LLC, Capital One Securities, Inc., CIBC World Markets Corp., Goldman Sachs & Co. LLC, Jefferies LLC, JMP Securities LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Regions Securities LLC, Scotia Capital (USA) Inc., Truist Securities, Inc. and Wells Fargo Securities, LLC, each a sales agent and, collectively, the sales agents, and, if applicable, the relevant forward purchasers (as defined below), relating to the sale of shares of our common stock, $0.01 par value per share, or common stock, having an aggregate offering price of up to $1,250,000,000, to be made from time to time under this prospectus supplement and the accompanying prospectus through the sales agents, as our sales agents or, if applicable, as forward sellers (as defined below), or directly to the sales agents as principals for their own accounts. Upon entry into the equity distribution agreements, we terminated our prior at-the-market program. At the time of such termination, $165.4 million remained unsold under such prior program.
Our common stock is listed on the New York Stock Exchange, or NYSE, under the symbol “REXR.” The last reported sale price of our common stock on the NYSE on February 16, 2023 was $61.85 per share.
Sales of shares of common stock, if any, under this prospectus supplement and the accompanying prospectus may be made in negotiated transactions or transactions that are deemed to be “at the market” offerings as defined in Rule 415 under the Securities Act of 1933, as amended, or the Securities Act, including sales made directly on the NYSE or sales made to or through a market maker other than on an exchange. The sales agents will make all sales on a best efforts basis using commercially reasonable efforts consistent with their normal trading and sales practices, on mutually agreed terms between the sales agents, the forward purchasers, if applicable, and us. The offering of the shares by the sales agents is subject to receipt and acceptance and subject to the sales agents’ right to reject any order in whole or in part.
Certain equity distribution agreements contemplate that, in addition to the issuance and sale by us of shares of our common stock to or through the sales agents, we may enter into separate forward sale agreements with each of BofA Securities, Inc., CIBC World Markets Corp., Goldman Sachs & Co. LLC, Jefferies LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Regions Securities LLC, Scotia Capital (USA) Inc., Truist Securities, Inc. and Wells Fargo Securities, LLC or one of their respective affiliates (in such capacity, each a forward purchaser and, collectively, the forward purchasers). If we enter into a forward sale agreement with any forward purchaser, we expect that such forward purchaser (or its affiliate) will attempt to borrow from third parties and sell, through the relevant sales agent, shares of our common stock to hedge such forward purchaser’s exposure under such forward sale agreement. We refer to a sales agent, when acting as sales agent for the relevant forward purchaser, as, individually, a forward seller and, collectively, the forward sellers. Unless otherwise expressly stated or the context otherwise requires, references herein to the “related” or “relevant” forward purchaser mean, with respect to any sales agent, the affiliate of such sales agent that is acting as forward purchaser or, if applicable, such sales agent acting in its capacity as forward purchaser. We will not receive any proceeds from any sale of shares of our common stock borrowed by a forward purchaser (or its affiliate) and sold through a forward seller.
We currently expect to fully physically settle each forward sale agreement, if any, with the relevant forward purchaser on one or more dates specified by us on or prior to the maturity date of such forward sale agreement, in which case we expect to receive aggregate net cash proceeds at settlement equal to the number of shares specified in such forward sale agreement multiplied by the relevant forward price per share. However, subject to certain exceptions, we may also elect, in our sole discretion, to cash settle or net share settle all or any portion of our obligations under any forward sale agreement, in which case we may not receive any proceeds (in the case of cash settlement) or will not receive any proceeds (in the case of net share settlement), and we may owe cash (in the case of cash settlement) or shares of our common stock (in the case of net share settlement) to the relevant forward purchaser. See “Plan of Distribution” in this prospectus supplement.
Each sales agent will receive from us a commission, at a mutually agreed rate up to 2.0% of the gross sales price of all shares sold through it under the applicable equity distribution agreement. Under the terms of the equity distribution agreements, we may also sell shares of our common stock to any of the sales agent, as principal for its own account, at a price to be agreed upon at the time of sale. If we sell our shares of common stock to a sales agent, as principal, we will enter into a separate terms agreement with the applicable sales agent and we will describe such agreement in a separate prospectus supplement or pricing supplement. In connection with each forward sale agreement, we will pay the applicable forward seller a commission, in the form of a reduction to the initial forward price under the related forward sale agreement, at a mutually agreed rate up to 2.0% of the gross sales price per share of the borrowed shares of our common stock sold through such forward seller during the applicable forward selling period for such shares (subject to certain possible adjustments to such gross sales price for daily accruals and any quarterly dividends having an “ex-dividend” date during such forward selling period). In connection with the sale of the common stock a sales agent may be deemed to be an “underwriter” within the meaning of the Securities Act, and the compensation paid to a sales agent may be deemed to be underwriting commissions or discounts.
No sales agent is required to sell any specific number or dollar amount of shares of our common stock but will use its commercially reasonable efforts consistent with its normal trading and sales practices and subject to the terms of the applicable equity distribution agreement and, in the case of shares offered through such sales agent as forward seller, the relevant forward sale agreement to sell the shares of our common stock offered by this prospectus supplement, as instructed by us and, in the case of shares offered through such sales agent as forward seller, the relevant forward purchaser.
The offering of shares of our common stock pursuant to the equity distribution agreements will terminate upon the earlier of (1) the sale of shares of our common stock subject to the equity distribution agreements having an aggregate gross sales price of $1.25 billion and (2) the termination of the equity distribution agreements by us, the sales agents or the forward purchasers.
We are organized and conduct our operations to qualify as a real estate investment trust, or REIT, for federal income tax purposes. To assist us in complying with certain federal income tax requirements applicable to REITs, our charter contains certain restrictions relating to the ownership and transfer of our stock, including an ownership limit of 9.8% of the outstanding shares of our common stock.
Investing in our common stock involves risks. See “Risk Factors” beginning on page S-4 of this prospectus supplement and the risks set forth under the caption “Item 1A. Risk Factors” included in our most recent Annual Report on Form 10-K and in our other periodic reports filed with the Securities and Exchange Commission and incorporated by reference herein.
Neither the Securities and Exchange Commission nor any state securities commission, nor any other regulatory body has approved or disapproved of these securities or determined if this prospectus supplement and the prospectus to which it relates are truthful and complete. Any representation to the contrary is a criminal offense.
| | |
BofA Securities | | BTIG |
Capital One Securities | | CIBC Capital Markets |
Goldman Sachs & Co. LLC | | Jefferies |
JMP Securities A CITIZENS COMPANY | | J.P. Morgan |
Mizuho | | Regions Securities LLC |
Scotiabank | | Truist Securities |
Wells Fargo Securities | | |
The date of this prospectus supplement is February 17, 2023.